Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricGEHCGE HealthCareRMDResMedDXCMDexcom
Snapshot
Price$71.22$233.33$90.10
Market cap$29.82B$30.41B$27.49B
Valuation
P/E17.4x22.3x37.7x
Forward P/E19.8x19.1x26.9x
Growth
Revenue growth6.0%10.3%16.1%
EPS growth-12.3%16.5%77.5%
Profitability
Net margin9.1%27.4%19.3%
ROE18.8%24.4%33.8%
Balance sheet & cash
Debt / equity0.97x0.11x0.47x
Free cash flow yield7.7%3.8%1.8%
Dividend yield0.2%1.2%—
Verdict
Investment ratingNeutral· 51Strong· 75Favorable· 70

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearGEHCtoday $71RMDtoday $233DXCMtoday $90
2027$54.48 – $79.91+12% CAGR$203.82 – $298.94+28% CAGR$119.91 – $175.87+95% CAGR
2028$55.57 – $81.51+7% CAGR$237.39 – $348.17+22% CAGR$212.78 – $312.08+86% CAGR
2029$56.68 – $83.14+5% CAGR$276.49 – $405.51+20% CAGR$377.58 – $553.79+83% CAGR
2030$57.82 – $84.80+4% CAGR$322.02 – $472.30+19% CAGR$670.02 – $982.70+82% CAGR
2031$58.97 – $86.50+4% CAGR$375.06 – $550.09+19% CAGR$1,188.96 – $1,743.80+81% CAGR
5-yr CAGR-3.7% – 4.0%10.0% – 18.7%67.5% – 80.9%